86 completed, 38 unknown, 11 terminated, 9 withdrawn. 151 Phase 3, 35 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 151 | Completed 86, Unknown 38, Terminated 11, Withdrawn 9, Active not recruiting 3, Recruiting 3, Suspended 1 |
| Phase 2 | 35 | Completed 19, Unknown 8, Withdrawn 4, Terminated 3, Recruiting 1 |
Follow Placebos: new trials by email Literature Review of Placebos trials Research Report on Placebos
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis BAT4406F, Placebos - Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS) | Phase 2 / Phase 3 | Recruiting | Bio-Thera Solutions | 192 | 2025-10-26 | 2026-04-03 |
| Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease Sildenafil, Placebos - Single-ventricle, Pulmonary Hypertension | Phase 3 | Withdrawn | University Hospital, Montpellier | 2023-06-01 | 2023-05-15 | |
| Dexmedetomidine and HIPEC Dexmedetomidine, Placebos - Inflammation, Cancer | Phase 2 / Phase 3 | Unknown | University of British Columbia | 20 | 2023-03-01 | 2022-11-03 |
| Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial Angiotensin 1-7, Placebos - Coronavirus, Respiratory Failure | Phase 2 / Phase 3 | Unknown | Erasme University Hospital | 60 | 2021-12-30 | 2021-08-02 |
| Comparison of Corticosteroids vs Placebo on Duration of Ventilatory Support During Severe Acute Exacerbations of COPD Patients in the ICU Methylprednisolone, Placebos - Chronic Obstructive Pulmonary Disease | Phase 3 | Completed | Versailles Hospital | 440 | 2021-10-25 | 2026-10-23 |
| Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair Testosterone cypionate, Placebos - Rotator Cuff Tears | Phase 2 / Phase 3 | Withdrawn | Orthopedic Institute, Sioux Falls, SD | 2021-08-01 | 2022-03-15 | |
| REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial Tamsulosin Hydrochloride, Placebos - Urinary Catheterization, Thoracic Surgery | Phase 3 | Unknown | McMaster University | 350 | 2021-07-30 | 2021-02-25 |
| A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China Felbinac Trometamol Injection, Placebos - Pain | Phase 3 | Completed | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 264 | 2021-07-23 | 2023-05-22 |
| Melatonin on Clock Genes in Parkinson's Disease Melatonin, Placebos - Parkinson Disease | Phase 2 / Phase 3 | Withdrawn | Instituto Mexicano del Seguro Social | 2021-05-01 | 2020-08-04 | |
| A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China Felbinac Trometamol Injection, Placebos - Pain | Phase 3 | Completed | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 306 | 2021-04-25 | 2023-05-22 |
| Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers Placebos, Baclofen 5 mg, Baclofen 10mg - Acute Pain, Analgesia | Phase 2 / Phase 3 | Terminated | University of Alabama at Birmingham | 19 | 2021-01-21 | 2026-01-07 |
| Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease Placebos, ZA Low dose, ZA high dose - Retinal Disorder | Phase 2 / Phase 3 | Withdrawn | Retinagenix Holdings | 2020-12-01 | 2023-02-24 | |
| Letrozole in Tubal Ectopic Pregnancy Placebos, Letrozole tablets - Tubal Pregnancy | Phase 3 | Unknown | Queen Mary Hospital, Hong Kong | 214 | 2020-12-01 | 2023-04-10 |
| Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients Artrodar, Placebos - Knee Osteoarthritis | Phase 3 | Active not recruiting | TRB Chemedica | 128 | 2020-11-22 | 2026-09-30 |
| Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection Vancomycin, Placebos - Clostridium Difficile Infection | Phase 3 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 263 | 2020-11-19 | 2025-12-10 |
| Heparin vs Placebo for Cardiac Catheterization Heparin, Placebos - Cardiac Disease | Phase 3 | Recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1623 | 2020-10-05 | 2026-02-20 |
| Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion Placebos, Dobutamine - Sepsis, Cardiomyopathies | Phase 3 | Completed | University Hospital, Limoges | 136 | 2020-09-20 | 2025-11-21 |
| Measles Vaccine in HCW Measles-Mumps-Rubella Vaccine, Placebos - Covid19 | Phase 3 | Suspended | Kasr El Aini Hospital | 200 | 2020-07-13 | 2020-12-22 |
| Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies Tranexamic Acid, Placebos - Fibroid Uterus, Abnormal Uterine Bleeding | Phase 3 | Unknown | Eastern Virginia Medical School | 50 | 2020-06-20 | 2023-09-11 |
| Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS) Levosimendan, Placebos - Cardiac Output, Low | Phase 2 / Phase 3 | Unknown | María de los Ángeles Tena Pajuelo | 300 | 2020-06-17 | 2020-07-24 |
Showing 20 of 151. Sign in to see all of them.
COVID-19 (4) · Dermatitis, Atopic (4) · Heart Failure (3) · Neoplasms (3) · Osteoarthritis, Knee (3) · Ovarian Neoplasms (3) · Acute Pain (2) · Agnosia (2) · Atrial Fibrillation (2) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Coronavirus Infections (2) · Dry Eye Syndromes (2) · Fetal Growth Retardation (2) · Growth Disorders (2)
John Paul II Hospital, Krakow (3) · Mayo Clinic (3) · CHU de Quebec-Universite Laval (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2) · Fakultas Kedokteran Universitas Indonesia (2) · Novartis Pharmaceuticals (2) · Ocugen (2) · Otsuka Pharmaceutical Co., Ltd. (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · Revance Therapeutics, Inc. (2) · Shanghai Henlius Biotech (2) · Shijiazhuang Yiling Pharmaceutical Co. Ltd (2) · University Hospital, Montpellier (2) · Yooyoung Pharmaceutical Co., Ltd. (2) · AGO Research GmbH (1)
United States (37) · China (23) · France (17) · Canada (13) · Spain (10) · Germany (9) · Poland (8) · South Korea (7) · United Kingdom (7) · Austria (6) · Egypt (6) · Italy (6) · Japan (6) · Australia (5) · Belgium (5)
Fernand Labrie, MD, PhD (2) · Leonello Cusan, MD, PhD (2) · Osamu Sato (2) · Ade Meidian Ambari, MD,FIHA (1) · Adrian Vella (1) · Alain Cariou, MD (1) · Aldo Sgaravatti, MD (1) · Amanda C Palmer, PhD (1) · Anat Berkovitch, resident (1) · Andrew McKeon, MD (1) · Anil Bhansali, DM (1) · Ashraf Moini, MD (1) · Ayesha Hamayun, MBBS, PhD (1)
PMID 31609882, PMID 31791824, PMID 10811917, PMID 16984654, PMID 17138963, PMID 17485450, PMID 18359622, PMID 19700350, PMID 19858734, PMID 20012748, PMID 20417240, PMID 21963186, PMID 21981277, PMID 22250028, PMID 22406244, PMID 23047939, PMID 23359581, PMID 23393105, PMID 23439457, PMID 23525934, PMID 23620700, PMID 23937996, PMID 24126568, PMID 24485867, PMID 25143025, PMID 25164872, PMID 26907795, PMID 26922562, PMID 27942865, PMID 28483817, PMID 28673265, PMID 28891408, PMID 28963290, PMID 29113955, PMID 29141611, PMID 29490185, PMID 29532502, PMID 29718383, PMID 29982218, PMID 30068669, PMID 30343620, PMID 30355790, PMID 30904834, PMID 30904852, PMID 30928620, PMID 31024734, PMID 31357887, PMID 31390660, PMID 31392541, PMID 31521118
2018 (6), 2017 (4), 2016 (1), 2019 (1), R01AG054366 (1), UM1AI068636 (1)